Roles of ginsenosides in sepsis.

Authors:
Yu T; Tang Y; Zhang F; Zhang L.

Journal:
J Ginseng Res

Publication Year: 2022

DOI:
10.1016/j.jgr.2022.05.004

PMCID:
PMC9834008

PMID:
36644389

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Ginseng Res

Abbreviation: J Ginseng Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Mass spectrometry-based ginsenoside profiling: Recent applications, limitations, and perspectives.
Kim HW; Kim DH; Ryu B and 11 more (2024) - Transparency Score: 3/6
Sustainable production of natural products using synthetic biology: Ginsenosides.
Son SH; Kang J; Shin Y and 4 more (2024) - Transparency Score: 3/6
20(S)-ginsenoside Rg3 exerts anti-fibrotic effect after myocardial infarction by alleviation of fib…
Xu H; Miao H; Chen G and 10 more (2023) - Transparency Score: 3/6
Age-induced Changes in Ginsenoside Accumulation and Primary Metabolic Characteristics of Panax Gins…
Yuan W; Wang QF; Pei WH and 6 more (2023) - Transparency Score: 3/6
Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppressi…
Kim J; Zhang S; Zhu Y and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no competing interests."

Evidence found in paper:

"This work was supported by The 10.13039/501100001809National Natural Science Foundation of China (grant no. 81973547)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025